Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
CSL Limited
CSL Limited
CSL · ASX

CSL Limited

AU$186.30

Price Arrow0.12 (0.064%)
28/11/2025 04:10:10 PM
All-CompaniesAll-ConsensusALL-RecommendationsASR Trading Report - AllASRW Investing ReportConsensus CheapGROWTH AUSHALO 100+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

CSL Limited Overview

CSL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Weak

Garp

Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Neutral

Quality

Capital Efficiency

Strong

Balance Sheet

Weak

About CSL

icon

Telephone

61.3.9389.1911

icon

Address

655 Elizabeth Street, Melbourne, Victoria (VIC) 3000

Description

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

CSL Price Chart

Key Stats

Market Cap

AU$90.33B

PE

27.20

EV/EBITDA

18

Dividends Overview

DIV Yield

1.6%

Franking

0%

Ex Dividend Date (est.)

09-Sep-25

Market Data

52 weeks range

Low 168 - 290.32

Trade Value (12mth)

US$37,086,105.00

1 week

1.83%

1 month

3.75%

YTD

-33.74%

1 year

-33.99%

All time high

342.75

Key Fundamentals

EPS 3 yr Growth

28.90%

EBITDA Margin

32.70%

Operating Cashflow

$3,561m

Free Cash Flow Return

12.40%

ROIC

10.50%

Interest Coverage

11.30

Quick Ratio

1.10

Other Data

Shares Outstanding (Fully Diluted)

486m

HALO Sector

Healthcare

Next Company Report Date

18-Aug-26

Next Ex Dividend Date

09-Sep-25

Next Dividend Pay Date

03-Oct-25

Reporting Currency

USD

Short Sell (% of issue)

0.19

CSL Announcements

Latest Announcements

DateAnnouncements
27 November 25
26 November 25
25 November 25
24 November 25
24 November 25

CSL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock4.655.476.2locklocklock
EPS (Fully Diluted)
$locklocklocklock4.645.456.17locklocklock
Growth
%locklocklocklock-3.217.513.4locklocklock
PE
Xlocklocklocklock32.933.927.2locklocklock
EV/EBITDA
Xlocklocklocklock21.922.318locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

09-Sep-25

DIV Yield

1.6%

Franking Level

0%

DPSg

13.1%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

0.44%

Value ($M)

387

Prior Change

0.1

7 Day Change

0.10%

1 Month Change

-0.10%

3 Months Change

0.10%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CSL Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of CSL Limited (CSL:ASX)?
Halo FAQ
The current share price of CSL Limited (CSL:ASX) is AUD$186.30.
What is the 52-week high share price for CSL Limited (CSL:ASX)?
Halo FAQ
The 52-week high share price for CSL Limited (CSL:ASX) is AUD$290.32.
What is the 52-week low share price for CSL Limited (CSL:ASX)?
Halo FAQ
The 52-week low share price for CSL Limited (CSL:ASX) is AUD$168.00.
What is the dividend yield for CSL Limited (CSL:ASX)?
Halo FAQ
The current TTM dividend payout for CSL Limited (CSL:ASX) is 1.60.
What was CSL Limited (CSL:ASX) last dividend payment?
Halo FAQ
The last dividend payment of CSL Limited (CSL:ASX) is AUD$2.45.
What is the franking level for CSL Limited (CSL:ASX)?
Halo FAQ
CSL Limited (CSL:ASX) has a franking level of 0.00%.
In which sector is CSL Limited (CSL:ASX) classified?
Halo FAQ
CSL Limited (CSL:ASX) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for CSL Limited (CSL:ASX)?
Halo FAQ
The current P/E ratio for CSL Limited (CSL:ASX) is 27.20.

See beyond the curve.

One solution for research, investing and portfolio management.